Frontiers reaches 6.4 on Journal Impact Factors

General Commentary ARTICLE

Front. Nutr., 16 December 2015 | https://doi.org/10.3389/fnut.2015.00037

Commentary: Rheumatoid Cachexia Revisited: A Metabolic Co-morbidity in Rheumatoid Arthritis

  • School of Sport, Health and Exercise Sciences, Bangor University, Bangor, UK

A commentary on

Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis
by Masuko K. Front Nutr (2014) 1:20. doi: 10.3389/fnut.2014.00020

The “mini review” by Masuko (1) contains a quite extensive summary of “rheumatoid cachexia” (2) [i.e., loss of muscle mass in rheumatoid arthritis (RA)], an often overlooked and misdiagnosed co-morbidity. Masuko looks at the definition of “rheumatoid cachexia,” as well as the pathogenesis of the condition referring to the key role of pro-inflammatory cytokines. Interestingly, various strategic therapy options designed to attenuate rheumatoid cachexia by disease-modifying anti-rheumatic drugs (DMARDS), anti-cytokine therapies, and exercise training (i.e., resistance and endurance) are covered.

However, what the review fails to mention or expand upon, is the relative ineffectiveness of exercise on “rheumatoid cachexia” once supervision is withdraw. The review also neglects to discuss (despite referencing a relevant trial) another potential key tool in the armory against “rheumatoid cachexia”: nutritional supplementation. This commentary will confine itself to briefly recounting some of these.

As Masuko states that resistance training is the most beneficial means to increase both lean mass and physical function in RA. Both Marcora et al. (3) and Lemmey et al. (4) showed that progressive resistance training (PRT) for a period of 12 and 24 weeks (exercising two and three times per week, respectively) was able to attenuate the effects of rheumatoid cachexia, specifically increasing lean mass, strength, and physical function in patients with RA. However, a follow-up study for 3 years later by Lemmey et al. (5) found that once supervision was withdrawn, no subjects from the original study (4) were performing relevant PRT or any other form of regular high intense exercise and, as a result, lean mass had regressed to baseline levels, as had much of the trunk fat mass and body fat percentage. Lack of adherence to high-intense exercise in RA has been demonstrated by others (6).

Unfortunately, it seems habitually performed, high-intensity exercise (i.e., PRT) is unlikely to be widely adopted as a general treatment strategy for reversing “rheumatoid cachexia” and restoring function, then the challenge to develop a treatment option that is easily administered, inexpensive, and makes limited demands of the patient remains. Anabolic nutritional supplementation offers a potential treatment option that is easily administered, inexpensive, and makes limited demands of the patient.

Scientific evidence continues to suggest that nutrition should be part of routine care in those with muscle wasting disorders [for review, see Stamp et al. (7)]. Specifically, up to 75% of RA patients believe that food and nutrition play an important role in their symptom severity, with 50% of RA patients reportedly trying some form of dietary manipulation in an attempt to attenuate symptomology (7). Marcora et al. (8) previously investigated the effects of daily 12 weeks of a mixture of β-hydroxy-β-methylbutyrate, glutamine, and arginine (HMB/GLN/ARG) protein supplementation in 40 RA patients. The results showed that both HMB/GLN/ARG and a control mixture of other non-essential amino acids (alanine, glutamic acid, glycine, and serine) were both equally effective in increasing lean mass (~0.4 kg) and improving some measures of physical function and strength.

Creatine monohydrate, a combination of essential amino acids, has generally been shown to be more effective in increasing lean mass and physical performance than other protein-based supplements, including HMB/GLN/ARG [for review, see Nissen (9)]. In the only study investigating the use of creatine in RA, Willer et al. (10) found that creatine supplementation increased muscle strength in 8 out of the 12 patients by an average of 14% as determined by the muscle strength index, although this increase in strength was not actually associated with changes of creatine (or phosphocreatine) levels in the muscle.

Nonetheless, creatine has been shown to be effective, without additional exercise training, in range of clinical populations, including muscular dystrophy patients and the elderly who, like RA patients, present with reduced muscle mass and impaired physical function [for review, see Wilkinson et al. (11)]. Evidently, more research is needed, and as such we have just completed a randomized control trial investigating the effects of creatine in RA patients (manuscript in preparation).

To summarize, although PRT exercise is arguably the most effective way to attenuate the effects of rheumatoid cachexia, due to its high-intense nature, it is unlikely to be widely adopted as a general treatment strategy. Nutritional supplementation, specifically those that focus on muscle anabolism may be a viable option. Alongside, HMB/GLN/ARG protein supplementation, creatine monohydrate may be a potential therapeutic option in RA, as it has been effective in range of clinical and elderly populations.

Conflict of Interest Statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

1. Masuko K. Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis. Front Nutr (2014) 1:20. doi:10.3389/fnut.2014.00020

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellmann DB. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol (1992) 19:1505–10. doi:10.1186/ar2658

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Marcora SM, Lemmey AB, Maddison PJ. Can progressive resistance training reverse cachexia in patients with rheumatoid arthritis? Results of a pilot study. J Rheumatol (2005) 32:1031–9.

PubMed Abstract | Google Scholar

4. Lemmey AB, Marcora SM, Chester K, Wilson S, Casanova F, Maddison PJ. Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial. Arthritis Rheum (2009) 61:1726–34. doi:10.1002/art.24891

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Lemmey AB, Williams SL, Marcora SM, Jones J, Maddison PJ. Are the benefits of a high-intensity progressive resistance training program sustained in rheumatoid arthritis patients? A 3-year followup study. Arthritis Care Res (Hoboken) (2012) 64:71–5. doi:10.1002/acr.20523

PubMed Abstract | CrossRef Full Text | Google Scholar

6. de Jong Z, Munneke M, Kroon HM, van Schaardenburg D, Dijkmans BA, Hazes JM, et al. Long-term follow-up of a high-intensity exercise program in patients with rheumatoid arthritis. Clin Rheumatol (2009) 28:663–71. doi:10.1007/s10067-009-1125-z

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Stamp LK, James MJ, Cleland LG. Diet and rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum (2005) 35:77–94. doi:10.1016/j.semarthrit.2005.05.001

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Marcora S, Lemmey A, Maddison P. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial. Clin Nutr (2005) 24:442–54. doi:10.1016/j.clnu.2005.01.006

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Nissen SL, Sharp RL. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol (1985) (2003) 94:651–9. doi:10.1152/japplphysiol.00755.2002

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Willer B, Stucki G, Hoppeler H, Brühlmann P, Krähenbühl S. Effects of creatine supplementation on muscle weakness in patients with rheumatoid arthritis. Rheumatology (Oxford) (2000) 39:293–8. doi:10.1093/rheumatology/39.3.293

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Wilkinson TJ, O’Brien TD, Lemmey AB. Oral creatine supplementation: a potential adjunct therapy for rheumatoid arthritis patients. World J Rheum (2014) 4:22–34. doi:10.5499/wjr.v4.i3.22

CrossRef Full Text | Google Scholar

Keywords: rheumatoid cachexia, cachexia, sarcopenia, inflammation, rheumatoid arthritis

Citation: Wilkinson TJ (2015) Commentary: Rheumatoid Cachexia Revisited: A Metabolic Co-morbidity in Rheumatoid Arthritis. Front. Nutr. 2:37. doi: 10.3389/fnut.2015.00037

Received: 13 July 2015; Accepted: 02 December 2015;
Published: 16 December 2015

Edited by:

Marc Poirot, Institut National de la Santé et de la Recherche Médicale, France

Reviewed by:

Luigi Iuliano, Sapienza University of Rome, Italy

Copyright: © 2015 Wilkinson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Thomas J. Wilkinson, tomwilks444@gmail.com